Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1993 Nov;80(3):477–487.

Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production.

A Saxon 1, B Keld 1, J Braun 1, A Dotson 1, N Sidell 1
PMCID: PMC1422223  PMID: 8288320

Abstract

We have previously shown that retinoids can induce differentiation of B cells in vitro as well as in vivo in patients with common variable immunodeficiency (CVI). While changes were observed over 1 week when retinoic acid (RA) was added to CVI hybridoma cells in vitro, maturation of the patients' B-cell compartment in vivo occurred only after 4 months of drug administration. We have now performed a 64-week open trial of oral 13-cis RA in five patients to see if prolonged treatment would result in continued improvement in their humoral immune compartment. In this trial, drug was given for 32 weeks followed by a 32-week wash-out period. During the treatment, the patients showed changes in a variety of parameters indicating an alteration towards normal of their humoral immune systems. This change included a fall in the elevated circulating interleukin-6 (IL-6) levels, a more normal display of B-cell surface markers (L-selectin and CD20), a decrease in B-cell size, and improved in vitro and in vivo B-cell function. In order to determine if VH gene use was affected by the retinoid treatment, VH gene expression in the CVI patients was characterized. Results showed an unusual predominance of non-mutated VH gene sequences, representative of cells that are recent bone marrow emigrants. While no common pattern of change occurred in VH gene segment use in the patients while on retinoid therapy, large-scale (> 10-fold) changes in the expression of these genes were observed in each individual over time. Taken together, these results provide multiple lines of evidence that 13-cis RA promotes maturation of B cells in patients with CVI. However, the effect appears to be partial, such that stimuli in addition to 13-cis RA will be necessary to provide for further B-cell differentiation in order to achieve normalization of humoral immunity.

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman D. C., Matsuda T., Hirano T., Kishimoto T., Saxon A. Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency. J Allergy Clin Immunol. 1990 Oct;86(4 Pt 1):512–521. doi: 10.1016/s0091-6749(05)80207-6. [DOI] [PubMed] [Google Scholar]
  2. Adelman D. C., Yen T. Y., Cumberland W. G., Sidell N., Saxon A. 13-cis retinoic acid enhances in vivo B-lymphocyte differentiation in patients with common variable immunodeficiency. J Allergy Clin Immunol. 1991 Nov;88(5):705–712. doi: 10.1016/0091-6749(91)90176-o. [DOI] [PubMed] [Google Scholar]
  3. Ashman R. F., Saxon A., Stevens R. H. Profile of multiple lymphocyte functional defects in acquired hypogrammaglobulinemia, derived from in vitro cell recombination analysis. J Allergy Clin Immunol. 1980 Apr;65(4):242–256. doi: 10.1016/0091-6749(80)90151-7. [DOI] [PubMed] [Google Scholar]
  4. Baumert E., Wolff-Vorbeck G., Schlesier M., Peter H. H. Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol. 1992 Oct;90(1):25–30. doi: 10.1111/j.1365-2249.1992.tb05826.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blomhoff H. K., Smeland E. B., Erikstein B., Rasmussen A. M., Skrede B., Skjønsberg C., Blomhoff R. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J Biol Chem. 1992 Nov 25;267(33):23988–23992. [PubMed] [Google Scholar]
  6. Braun J., Galbraith L., Valles-Ayoub Y., Saxon A. Human immunodeficiency resulting from a maturational arrest of germinal center B cells. Immunol Lett. 1991 Mar;27(3):205–208. doi: 10.1016/0165-2478(91)90152-z. [DOI] [PubMed] [Google Scholar]
  7. De Gast G. C., Wilkins S. R., Webster A. D., Rickinson A., Platts-Mills T. A. Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia. Clin Exp Immunol. 1980 Dec;42(3):535–544. [PMC free article] [PubMed] [Google Scholar]
  8. Douer D., Koeffler H. P. Retinoic acid enhances growth of human early erythroid progenitor cells in vitro. J Clin Invest. 1982 Apr;69(4):1039–1041. doi: 10.1172/JCI110507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Geha R. S., Schneeberger E., Merler E., Rosen F. S. Heterogeneity of "acquired" or common variable agammaglobulinemia. N Engl J Med. 1974 Jul 4;291(1):1–6. doi: 10.1056/NEJM197407042910101. [DOI] [PubMed] [Google Scholar]
  10. Green H. A., Moschella S. Multiple invasive squamous cell carcinomas and common variable immunodeficiency. Arch Dermatol. 1992 Mar;128(3):412–413. [PubMed] [Google Scholar]
  11. Hermans P. E., Diaz-Buxo J. A., Stobo J. D. Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med. 1976 Aug;61(2):221–237. doi: 10.1016/0002-9343(76)90173-x. [DOI] [PubMed] [Google Scholar]
  12. Huang C., Stewart A. K., Schwartz R. S., Stollar B. D. Immunoglobulin heavy chain gene expression in peripheral blood B lymphocytes. J Clin Invest. 1992 Apr;89(4):1331–1343. doi: 10.1172/JCI115719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jones B. M. Identification of B-cell and T-helper-cell defects, and of suppressor cell hyperactivity, in humoral immunodeficiency. Clin Immunol Immunopathol. 1984 Jul;32(1):41–51. doi: 10.1016/0090-1229(84)90041-2. [DOI] [PubMed] [Google Scholar]
  14. Liu Y. J., Cairns J. A., Holder M. J., Abbot S. D., Jansen K. U., Bonnefoy J. Y., Gordon J., MacLennan I. C. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol. 1991 May;21(5):1107–1114. doi: 10.1002/eji.1830210504. [DOI] [PubMed] [Google Scholar]
  15. Macy E., Kemeny M., Saxon A. Enhanced ELISA: how to measure less than 10 picograms of a specific protein (immunoglobulin) in less than 8 hours. FASEB J. 1988 Nov;2(14):3003–3009. doi: 10.1096/fasebj.2.14.3263291. [DOI] [PubMed] [Google Scholar]
  16. Matsuda T., Hirano T., Kishimoto T. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur J Immunol. 1988 Jun;18(6):951–956. doi: 10.1002/eji.1830180618. [DOI] [PubMed] [Google Scholar]
  17. Mortari F., Newton J. A., Wang J. Y., Schroeder H. W., Jr The human cord blood antibody repertoire. Frequent usage of the VH7 gene family. Eur J Immunol. 1992 Jan;22(1):241–245. doi: 10.1002/eji.1830220135. [DOI] [PubMed] [Google Scholar]
  18. Richards S. J., Scott C. S., Cole J. C., Gooi H. C. Abnormal CD45R expression in patients with common variable immunodeficiency and X-linked agammaglobulinaemia. Br J Haematol. 1992 Jun;81(2):160–166. doi: 10.1111/j.1365-2141.1992.tb08201.x. [DOI] [PubMed] [Google Scholar]
  19. Saiki O., Ralph P., Cunningham-Rundles C., Good R. A. Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A. 1982 Oct;79(19):6008–6012. doi: 10.1073/pnas.79.19.6008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sanz I., Kelly P., Williams C., Scholl S., Tucker P., Capra J. D. The smaller human VH gene families display remarkably little polymorphism. EMBO J. 1989 Dec 1;8(12):3741–3748. doi: 10.1002/j.1460-2075.1989.tb08550.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Saxon A., Feldhaus J., Robins R. A. Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods. 1976;12(3-4):285–288. doi: 10.1016/0022-1759(76)90050-8. [DOI] [PubMed] [Google Scholar]
  22. Saxon A., Giorgi J. V., Sherr E. H., Kagan J. M. Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule display. J Allergy Clin Immunol. 1989 Jul;84(1):44–55. doi: 10.1016/0091-6749(89)90177-2. [DOI] [PubMed] [Google Scholar]
  23. Saxon A., Macy E., Denis K., Tary-Lehmann M., Witte O., Braun J. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest. 1991 Feb;87(2):658–665. doi: 10.1172/JCI115043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Saxon A., Sidell N., Zhang K. B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation. Cell Immunol. 1992 Oct 1;144(1):169–181. doi: 10.1016/0008-8749(92)90234-g. [DOI] [PubMed] [Google Scholar]
  25. Schroeder H. W., Jr, Hillson J. L., Perlmutter R. M. Early restriction of the human antibody repertoire. Science. 1987 Nov 6;238(4828):791–793. doi: 10.1126/science.3118465. [DOI] [PubMed] [Google Scholar]
  26. Sherr E., Adelman D. C., Saxon A., Gilly M., Wall R., Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. J Exp Med. 1988 Jul 1;168(1):55–71. doi: 10.1084/jem.168.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sidell N., Connor M. J., Chang B., Lowe N. J., Borok M. Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens. J Invest Dermatol. 1990 Nov;95(5):597–602. doi: 10.1111/1523-1747.ep12505593. [DOI] [PubMed] [Google Scholar]
  28. Sidell N., Taga T., Hirano T., Kishimoto T., Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol. 1991 Jun 1;146(11):3809–3814. [PubMed] [Google Scholar]
  29. Siegal F. P., Siegal M., Good R. A. Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias. N Engl J Med. 1978 Jul 27;299(4):172–178. doi: 10.1056/NEJM197807272990404. [DOI] [PubMed] [Google Scholar]
  30. Stohl W., Cunningham-Rundles C., Mayer L. In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency. Clin Immunol Immunopathol. 1988 Nov;49(2):273–282. doi: 10.1016/0090-1229(88)90117-1. [DOI] [PubMed] [Google Scholar]
  31. Zhang K., Clark E. A., Saxon A. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol. 1991 Mar 15;146(6):1836–1842. [PubMed] [Google Scholar]
  32. Zhang K., Clark E. A., Saxon A. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production. J Immunol. 1991 Mar 15;146(6):1836–1842. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES